acquired-demyelinating-syndromes-survey-questions.p65

First Page		Document Content
Date: 2012-10-22 14:28:53 Health Anatomy Neurology Acute disseminated encephalomyelitis Demyelinating disease Myelin Transverse myelitis Peripheral neuropathy Encephalomyelitis Neurological disorders Multiple sclerosis Autoimmune diseases		acquired-demyelinating-syndromes-survey-questions.p65 Add to Reading List Source URL: www.cpsp.cps.ca Download Document from Source Website File Size: 86,58 KB Share Document on Facebook

	ISOFENPHOS Isofenphos is rated by the EPA as a highly toxic organophosphate and capable of altering function of the brain, peripheral nerves and autonomic nerves.1 It is capable of causing delayed neuropathy in mammal DocID: 1srMF - View Document
	Original Article Journal of CLINICAL NEUROMUSCULAR DocID: 1rfku - View Document
	Microsoft Word - Fact Sheet on Botulism Following Botulinum Toxin Injection_16 DocID: 1r752 - View Document
	Regulation of Spinal Fractalkine/CX3CR1 and TNF-alpha Signaling in Paclitaxel Induced Peripheral Neuropathy in Rats Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially severe and dose-limiting adve DocID: 1qSei - View Document
	Neural Sensitization: The Medical Key to Treatment for Chemical Injury Science Based Treatment INTRODUCTION Chemical injury can cause chronic damage to body biochemistry. This involves a biochemical vicious cycle often c DocID: 1pCTO - View Document